1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Abdominal Aortic Aneurysm Repair Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Abdominal Aortic Aneurysm Repair Market, by Treatment Type
8.1.1. Endovascular Aneurysm Repair (EVAR)
8.1.1.1. Market Revenue and Forecast
8.1.2. Open Surgical Repair (OSR)
8.1.2.1. Market Revenue and Forecast
9.1. Abdominal Aortic Aneurysm Repair Market, by Product Type
9.1.1. Stent Grafts / Endografts
9.1.1.1. Market Revenue and Forecast
9.1.2. Catheters & Delivery Systems
9.1.2.1. Market Revenue and Forecast
10.1. Abdominal Aortic Aneurysm Repair Market, by Aneurysm Site
10.1.1. Infrarenal AAA
10.1.1.1. Market Revenue and Forecast
10.1.2. Pararenal AAA
10.1.2.1. Market Revenue and Forecast
11.1. Abdominal Aortic Aneurysm Repair Market, by End-User
11.1.1. Hospitals
11.1.1.1. Market Revenue and Forecast
11.1.2. Ambulatory Surgical Centers (ASCs)
11.1.2.1. Market Revenue and Forecast
11.1.3. Specialty Clinics
11.1.3.1. Market Revenue and Forecast
12.1. Abdominal Aortic Aneurysm Repair Market, by Technique
12.1.1. Standard EVAR
12.1.1.1. Market Revenue and Forecast
12.1.2. Fenestrated EVAR (FEVAR)
12.1.2.1. Market Revenue and Forecast
12.1.3. Branched / Hybrid EVAR
12.1.3.1. Market Revenue and Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Treatment Type
13.1.2. Market Revenue and Forecast, by Product Type
13.1.3. Market Revenue and Forecast, by Aneurysm Site
13.1.4. Market Revenue and Forecast, by End-User
13.1.5. Market Revenue and Forecast, by Technique
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Treatment Type
13.1.6.2. Market Revenue and Forecast, by Product Type
13.1.6.3. Market Revenue and Forecast, by Aneurysm Site
13.1.6.4. Market Revenue and Forecast, by End-User
13.1.6.5. Market Revenue and Forecast, by Technique
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Forecast, by Treatment Type
13.1.7.2. Market Revenue and Forecast, by Product Type
13.1.7.3. Market Revenue and Forecast, by Aneurysm Site
13.1.7.4. Market Revenue and Forecast, by End-User
13.1.7.5. Market Revenue and Forecast, by Technique
13.2. Europe
13.2.1. Market Revenue and Forecast, by Treatment Type
13.2.2. Market Revenue and Forecast, by Product Type
13.2.3. Market Revenue and Forecast, by Aneurysm Site
13.2.4. Market Revenue and Forecast, by End-User
13.2.5. Market Revenue and Forecast, by Technique
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Treatment Type
13.2.6.2. Market Revenue and Forecast, by Product Type
13.2.6.3. Market Revenue and Forecast, by Aneurysm Site
13.2.7. Market Revenue and Forecast, by End-User
13.2.8. Market Revenue and Forecast, by Technique
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Treatment Type
13.2.9.2. Market Revenue and Forecast, by Product Type
13.2.9.3. Market Revenue and Forecast, by Aneurysm Site
13.2.10. Market Revenue and Forecast, by End-User
13.2.11. Market Revenue and Forecast, by Technique
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Treatment Type
13.2.12.2. Market Revenue and Forecast, by Product Type
13.2.12.3. Market Revenue and Forecast, by Aneurysm Site
13.2.12.4. Market Revenue and Forecast, by End-User
13.2.13. Market Revenue and Forecast, by Technique
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Treatment Type
13.2.14.2. Market Revenue and Forecast, by Product Type
13.2.14.3. Market Revenue and Forecast, by Aneurysm Site
13.2.14.4. Market Revenue and Forecast, by End-User
13.2.15. Market Revenue and Forecast, by Technique
13.3. APAC
13.3.1. Market Revenue and Forecast, by Treatment Type
13.3.2. Market Revenue and Forecast, by Product Type
13.3.3. Market Revenue and Forecast, by Aneurysm Site
13.3.4. Market Revenue and Forecast, by End-User
13.3.5. Market Revenue and Forecast, by Technique
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Treatment Type
13.3.6.2. Market Revenue and Forecast, by Product Type
13.3.6.3. Market Revenue and Forecast, by Aneurysm Site
13.3.6.4. Market Revenue and Forecast, by End-User
13.3.7. Market Revenue and Forecast, by Technique
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Treatment Type
13.3.8.2. Market Revenue and Forecast, by Product Type
13.3.8.3. Market Revenue and Forecast, by Aneurysm Site
13.3.8.4. Market Revenue and Forecast, by End-User
13.3.9. Market Revenue and Forecast, by Technique
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Treatment Type
13.3.10.2. Market Revenue and Forecast, by Product Type
13.3.10.3. Market Revenue and Forecast, by Aneurysm Site
13.3.10.4. Market Revenue and Forecast, by End-User
13.3.10.5. Market Revenue and Forecast, by Technique
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Treatment Type
13.3.11.2. Market Revenue and Forecast, by Product Type
13.3.11.3. Market Revenue and Forecast, by Aneurysm Site
13.3.11.4. Market Revenue and Forecast, by End-User
13.3.11.5. Market Revenue and Forecast, by Technique
13.4. MEA
13.4.1. Market Revenue and Forecast, by Treatment Type
13.4.2. Market Revenue and Forecast, by Product Type
13.4.3. Market Revenue and Forecast, by Aneurysm Site
13.4.4. Market Revenue and Forecast, by End-User
13.4.5. Market Revenue and Forecast, by Technique
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Treatment Type
13.4.6.2. Market Revenue and Forecast, by Product Type
13.4.6.3. Market Revenue and Forecast, by Aneurysm Site
13.4.6.4. Market Revenue and Forecast, by End-User
13.4.7. Market Revenue and Forecast, by Technique
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Treatment Type
13.4.8.2. Market Revenue and Forecast, by Product Type
13.4.8.3. Market Revenue and Forecast, by Aneurysm Site
13.4.8.4. Market Revenue and Forecast, by End-User
13.4.9. Market Revenue and Forecast, by Technique
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Treatment Type
13.4.10.2. Market Revenue and Forecast, by Product Type
13.4.10.3. Market Revenue and Forecast, by Aneurysm Site
13.4.10.4. Market Revenue and Forecast, by End-User
13.4.10.5. Market Revenue and Forecast, by Technique
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Treatment Type
13.4.11.2. Market Revenue and Forecast, by Product Type
13.4.11.3. Market Revenue and Forecast, by Aneurysm Site
13.4.11.4. Market Revenue and Forecast, by End-User
13.4.11.5. Market Revenue and Forecast, by Technique
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Treatment Type
13.5.2. Market Revenue and Forecast, by Product Type
13.5.3. Market Revenue and Forecast, by Aneurysm Site
13.5.4. Market Revenue and Forecast, by End-User
13.5.5. Market Revenue and Forecast, by Technique
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Treatment Type
13.5.6.2. Market Revenue and Forecast, by Product Type
13.5.6.3. Market Revenue and Forecast, by Aneurysm Site
13.5.6.4. Market Revenue and Forecast, by End-User
13.5.7. Market Revenue and Forecast, by Technique
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Treatment Type
13.5.8.2. Market Revenue and Forecast, by Product Type
13.5.8.3. Market Revenue and Forecast, by Aneurysm Site
13.5.8.4. Market Revenue and Forecast, by End-User
13.5.8.5. Market Revenue and Forecast, by Technique
14.1. Medtronic plc
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. W. L. Gore & Associates
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Cook Medical
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Terumo Corporation
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Endologix LLC
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Cardinal Health
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Boston Scientific Corporation
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Abbott Laboratories
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Becton Dickinson and Company
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. MicroPort Scientific Corporation
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
16.1. About Us
16.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
